plumbagin has been researched along with Cancer of Ovary in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, GH; Li, SY; Lin, CH; Shen, CC; Sun, CM; Syu, WJ | 1 |
| Chen, Y; Huang, S; Liang, K; Pan, X | 1 |
| Banerji, A; G, R; G, S; K A, T; K C, S; Nair, RS; Somasundaram, V; Srinivas, P; T, R | 1 |
| Bhattacharya, R; Cao, Y; Couch, FJ; Dutta, S; Elkhanany, A; Iyer, S; Mondal, G; Mukhopadhyay, D; Pal, K; Shridhar, V; Sinha, S; Somasundaram, V; Srinivas, P | 1 |
| Annab, LA; Banerji, A; Gopinath, G; Srinivas, G; Srinivas, P | 1 |
| Priya, S; Rakesh, S; Ratheeshkumar, T; Rojini, G; Srinivas, G; Thasni, KA | 1 |
6 other study(ies) available for plumbagin and Cancer of Ovary
| Article | Year |
|---|---|
Antimicrobial activities of naphthazarins from Arnebia euchroma.
Topics: Anti-Bacterial Agents; Boraginaceae; Carcinoma, Hepatocellular; China; Drug Screening Assays, Antitumor; Electron Spin Resonance Spectroscopy; Enterococcus faecalis; Female; HeLa Cells; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Naphthoquinones; Nuclear Magnetic Resonance, Biomolecular; Ovarian Neoplasms; Plant Bark; Plants, Medicinal; Staphylococcus aureus; Stereoisomerism; Tumor Cells, Cultured; Vancomycin | 2002 |
Anti-ovarian cancer actions and pharmacological targets of plumbagin.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Humans; Ovarian Neoplasms; RNA, Messenger | 2023 |
Structure activity relationship of plumbagin in BRCA1 related cancer cells.
Topics: Antineoplastic Agents, Phytogenic; BRCA1 Protein; Breast Neoplasms; Cell Cycle Checkpoints; Drug Screening Assays, Antitumor; Estrogen Receptor alpha; Female; Gene Knockout Techniques; Humans; Membrane Potential, Mitochondrial; Molecular Docking Simulation; Naphthoquinones; Ovarian Neoplasms; Poly(ADP-ribose) Polymerases; Response Elements; Structure-Activity Relationship; Transcriptome | 2013 |
Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; BRCA2 Protein; Calcium; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cisplatin; Endothelial Cells; Female; Glucose Transporter Type 1; Humans; Ki-67 Antigen; Mice; Mice, SCID; Naphthoquinones; Neovascularization, Pathologic; Ovarian Neoplasms; Platelet Endothelial Cell Adhesion Molecule-1; Random Allocation; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2013 |
Antisense blocking of BRCA1 enhances sensitivity to plumbagin but not tamoxifen in BG-1 ovarian cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; BRCA1 Protein; Cell Division; Emodin; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; In Situ Nick-End Labeling; Membrane Potentials; Mitochondria; Naphthoquinones; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; RNA, Antisense; RNA, Messenger; Tamoxifen; Tumor Cells, Cultured | 2004 |
Estrogen-dependent cell signaling and apoptosis in BRCA1-blocked BG1 ovarian cancer cells in response to plumbagin and other chemotherapeutic agents.
Topics: Actins; Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Line, Tumor; Cisplatin; Doxorubicin; Estrogen Receptor alpha; Female; Genes, BRCA1; Humans; Lethal Dose 50; Naphthoquinones; Ovarian Neoplasms; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Signal Transduction; Tamoxifen; Transfection; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases | 2008 |